A mGlu2/3 Agonist in the Treatment of PTSD
This study has public registry information. It focuses on PTSD and currently lists study information in Global.
In Global
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study has public registry information. It focuses on PTSD and currently lists study information in Global.
In GlobalThis study is completed. It focuses on PTSD and currently lists study information in the United States.
In DenverThis study is completed. It focuses on addiction and currently lists study information in the United States.
In NewtonThis study is completed. It focuses on bipolarity and currently lists study information in the United States.
In ChicagoThis study is completed. It focuses on PTSD and currently lists study information in the United States.
In TampaThis study is ongoing in France. It is testing CYR-101 for schizophrenia.
In FranceThis study has public registry information. It focuses on PTSD and currently lists study information in the United States.
Multiple locations, including RockvilleThis study is completed in the United States, in Canada, and in Israel. It is testing MDMA-Assisted Psychotherapy for PTSD.
Multiple locations, including Los AngelesThis study is completed in the United States, in Canada, and in Israel. It is testing MDMA-Assisted Psychotherapy for PTSD.
Multiple locations, including North HollywoodThis study is completed in the United States and in Israel. It is testing MDMA-Assisted Psychotherapy for PTSD.
Multiple locations, including Los AngelesThis study is completed in Japan. It is testing Safety and Efficacy of Long-term Administration of Aripiprazole for Bipolarity.
Multiple locations, including Chugoku RegionThis study is completed in China, in Japan, in South Korea, .... It is testing safety and Efficacy of Extended Administration of Aripiprazole for Bipolarity.
Multiple locations, including Hong KongHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.